Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/elysium-therapeutics-to-participate-in-the-2025-bio-international-convention-to-discuss-challenge-of-fentanyl-rebound-and-rescue-medication-designed-for-synthetic-opioids-302473757.html
12 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/elysium-therapeutics-to-host-investor-webcast-highlighting-soopr-program-and-the-need-to-address-fentanyl-rebound-as-key-challenge-in-the-opioid-overdose-epidemic-302452576.html
07 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/elysium-therapeutics-announces-development-of-overdose-rescue-technology-specifically-designed-for-oral-fentanyl-302421250.html
03 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/elysium-therapeutics-presents-phase-1-proof-of-concept-results-for-novel-smart-o2p-opioid-technology-for-acute-pain-that-reduces-the-potential-for-abuse-diversion-and-risk-of-oral-overdose-at-painweek-2024-302235155.html
ABOUT THIS PAGE